Cargando…

miR-210 is a Serological Biomarker for Predicting Recurrence and Prognosis of Colon Carcinoma Patients with Liver Metastases After Radiofrequency Ablation Treatment

PURPOSE: Hepatic metastasis of colon carcinoma seriously affects the prognosis of patients, and miRNA has attracted much attention in predicting hepatic metastasis of colon carcinoma (CC). This research aimed to explore the predictive role of miR-210 in serum for recurrence and prognosis of CC patie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Yong, Zhou, Yu-Mei, Zhang, Zu-Jian, Li, Xin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7524199/ https://www.ncbi.nlm.nih.gov/pubmed/33061602 http://dx.doi.org/10.2147/CMAR.S267731

Ejemplares similares

Expressions of miR-21 and miR-210 in Breast Cancer and Their Predictive Values for Prognosis
por: WU, Xiaofei
Publicado: (2020)

Combined prediction of miR‐210 and miR‐374a for severity and prognosis of hypoxic–ischemic encephalopathy
por: Wang, Zhansheng, et al.
Publicado: (2017)

Clinical analysis of ultrasound-guided radiofrequency ablation for recurrent colorectal liver metastases after hepatectomy
por: Fan, Xiao-xiang, et al.
Publicado: (2020)

Effects of surgery and radiofrequency ablation in the treatment of spinal metastases and analysis of the influencing factors of prognosis
por: Li, Meiling, et al.
Publicado: (2020)

miR-210 and miR-152 as Biomarkers by Liquid Biopsy in Invasive Ductal Carcinoma
por: Lopes, Beatriz C., et al.
Publicado: (2021)

Microwave ablation versus radiofrequency ablation for treating spinal metastases
por: Yao, Yuming, et al.
Publicado: (2023)

Overexpression of miR-210 is Associated with Poor Prognosis of Acute Myeloid Leukemia
por: Tang, Xiaoqiong, et al.
Publicado: (2015)

MiR210 in neonatal hypoxic-ischemic encephalopathy
por: Ma, Qingyi, et al.
Publicado: (2017)

MiR-210: an important player in the pathogenesis of preeclampsia?
por: Liu, Changjiang, et al.
Publicado: (2012)

Biomarkers and arrhythmia recurrence following radiofrequency ablation of atrial fibrillation
por: Carballo, David, et al.
Publicado: (2018)

Long Noncoding RNA miR210HG as a Potential Biomarker for the Diagnosis of Glioma
por: Min, Weijie, et al.
Publicado: (2016)

Radiofrequency ablation of osseous metastases for the palliation of pain
por: Thanos, L., et al.
Publicado: (2008)

Expression of miR-210, miR-137, and miR-153 in Patients with Acute Cerebral Infarction
por: Tian, Hongtao, et al.
Publicado: (2021)

The functional and predictive roles of miR-210 in cryptorchidism
por: Duan, Zhengzheng, et al.
Publicado: (2016)

Roles of miR-210 in the pathogenesis of pre-eclampsia
por: Li, Jiyun, et al.
Publicado: (2018)

Circulating MiR-210 and MiR-1246 as Potential Biomarkers for Differentiating Hepatocellular Carcinoma from Metastatic Tumors in the Liver
por: Ahmed, Emad K., et al.
Publicado: (2019)

Up-Regulation of hsa-miR-210 Promotes Venous Metastasis and Predicts Poor Prognosis in Hepatocellular Carcinoma
por: Ji, Jia, et al.
Publicado: (2018)

Involvement of upregulation of miR-210 in a rat epilepsy model
por: Chen, Licheng, et al.
Publicado: (2016)

Impact of Systemic Therapy and Recurrence Pattern on Survival Outcome after Radiofrequency Ablation for Colorectal Liver Metastases
por: Stang, Axel, et al.
Publicado: (2016)

Diagnostic Value of Plasma miR-181b, miR-196a, and miR-210 Combination in Pancreatic Cancer
por: Liu, Gongpan, et al.
Publicado: (2020)

Multiple functions of hypoxia-regulated miR-210 in cancer
por: Qin, Qin, et al.
Publicado: (2014)

The Role of Hypoxia-Induced miR-210 in Cancer Progression
por: Dang, Kyvan, et al.
Publicado: (2015)

MiR-210 and miR-155 as potential diagnostic markers for pre-eclampsia pregnancies
por: Gan, Lu, et al.
Publicado: (2017)

Does Radiofrequency Ablation Add to Chemotherapy for Unresectable Liver Metastases?
por: Govaert, Klaas M., et al.
Publicado: (2012)

Successful radiofrequency ablation of liver metastases from prostate cancer
por: Hino, Daichi, et al.
Publicado: (2022)

Plasma Level of MicroRNAs, MiR-107, MiR-194 and MiR-210 as Potential Biomarkers for Diagnosis Intestinal-Type Gastric Cancer in Human
por: Parvaee, Pegah, et al.
Publicado: (2019)

Radiofrequency ablation in experimental bone metastases using a controlled and navigated ablation device
por: Proschek, D., et al.
Publicado: (2012)

Safeness of Simultaneous Colonic Resection and Hepatic Radiofrequency Ablation
por: Hamzaoui, Yanis, et al.
Publicado: (2022)

Spontaneous Regression of Pulmonary and Adrenal Metastases Following Percutaneous Radiofrequency Ablation of a Recurrent Renal Cell Carcinoma
por: Kim, Heejung, et al.
Publicado: (2008)

Regulation of microRNA in systemic lupus erythematosus: the role of miR-21 and miR-210
por: Kourti, Maria, et al.
Publicado: (2020)

AB113. The function of miR-210 in varicocele rats with infertility
por: Chen, Yegang
Publicado: (2016)

Overexpression of miR-210 and its significance in ischemic tissue damage
por: Zaccagnini, G., et al.
Publicado: (2017)

Elevation of Circulating miR-210-3p in High-Altitude Hypoxic Environment
por: Yan, Yan, et al.
Publicado: (2016)

Association of miR-548c-5p, miR-7-5p, miR-210-3p, miR-128-3p with recurrence in systemically untreated breast cancer
por: Block, Ines, et al.
Publicado: (2018)

A Place for Radiofrequency Ablation in the Treatment of Resectable Colorectal Liver Metastases?
por: de Meijer, V. E., et al.
Publicado: (2008)

Comparative analysis of radiofrequency ablation and surgical resection for colorectal liver metastases
por: Kim, Kyung Ho, et al.
Publicado: (2011)

Radiofrequency ablation as a treatment tool for liver metastases of colorectal origin
por: Hompes, D., et al.
Publicado: (2011)

Oncological outcomes and predictors of radiofrequency ablation of colorectal cancer liver metastases
por: Wang, Chuan-Zhuo, et al.
Publicado: (2020)

Predictive value of miR-210 as a novel biomarker for pre-eclampsia: a systematic review protocol
por: Nikuei, Pooneh, et al.
Publicado: (2016)

Secreted miR-210-3p as non-invasive biomarker in clear cell renal cell carcinoma
por: Petrozza, Vincenzo, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_fed742i5n4jmmvgaop3lo5mm8s